Choreo, LLC Rani Therapeutics Holdings, Inc. Transaction History
Choreo, LLC
- $6.88 Billion
- Q4 2024
A detailed history of Choreo, LLC transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Choreo, LLC holds 11,813 shares of RANI stock, worth $16,892. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,813Holding current value
$16,892% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RANI
# of Institutions
39Shares Held
5.81MCall Options Held
2.5KPut Options Held
2.2K-
Armistice Capital, LLC New York, NY2.57MShares$3.68 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA710KShares$1.02 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$705,8251.04% of portfolio
-
Alphabet Inc. Mountain View, CA448KShares$641,3430.07% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$432,9220.02% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $35M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...